Therapeutic efficacy of lipid emulsions of docetaxel‐linoleic acid conjugate in breast cancer
暂无分享,去创建一个
Tao Zhang | M. Li | Yongjun Wang | Huicong Zhang | Dan Liu | Jibin Guan | D. Zhang | Shenwu Zhang | Ruyi Yang | Bin Yang | Jiang Yu | Jiang Yu | Zhang Tao
[1] P. Ganz,et al. Chemotherapy-Associated Peripheral Neuropathy in Patients With Early-Stage Breast Cancer: A Systematic Review. , 2018, Journal of the National Cancer Institute.
[2] Hongzhuo Liu,et al. Research progress of self-assembled nanogel and hybrid hydrogel systems based on pullulan derivatives , 2018, Drug delivery.
[3] Xing Tang,et al. A parenteral docetaxel‐loaded lipid microsphere with decreased 7‐epidocetaxel conversion in vitro and in vivo , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[4] J. Feijen,et al. cRGD/TAT Dual-Ligand Reversibly Cross-Linked Micelles Loaded with Docetaxel Penetrate Deeply into Tumor Tissue and Show High Antitumor Efficacy in Vivo. , 2017, ACS applied materials & interfaces.
[5] J. Wietrzyk,et al. Synthesis and evaluation of cytotoxic activity of conjugated linoleic acid derivatives (esters, alcohols, and their acetates) toward cancer cell lines , 2017 .
[6] I. Vhora,et al. Liposomes co-Loaded with 6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3 (PFKFB3) shRNA Plasmid and Docetaxel for the Treatment of non-small Cell Lung Cancer , 2017, Pharmaceutical Research.
[7] Jinhua Dong,et al. Combination of l-Carnitine with Lipophilic Linkage-Donating Gemcitabine Derivatives as Intestinal Novel Organic Cation Transporter 2-Targeting Oral Prodrugs. , 2017, Journal of medicinal chemistry.
[8] M. Ebrahimi,et al. Conjugated linoleic acid as functional food in poultry products: A review , 2017 .
[9] A. Pappenberger,et al. If Euhydric and Isotonic Do Not Work, What Are Acceptable pH and Osmolality for Parenteral Drug Dosage Forms? , 2017, Journal of pharmaceutical sciences.
[10] Bingjun Sun,et al. Self-delivering prodrug-nanoassemblies fabricated by disulfide bond bridged oleate prodrug of docetaxel for breast cancer therapy , 2017, Drug delivery.
[11] H. Takeuchi,et al. Effect of high-pressure homogenization on stability of emulsions containing zein and pectin , 2016, Asian journal of pharmaceutical sciences.
[12] Donghua Di,et al. Core-matched encapsulation of an oleate prodrug into nanostructured lipid carriers with high drug loading capability to facilitate the oral delivery of docetaxel. , 2016, Colloids and surfaces. B, Biointerfaces.
[13] N. Zhang,et al. Redox-Sensitive Citronellol-Cabazitaxel Conjugate: Maintained in Vitro Cytotoxicity and Self-Assembled as Multifunctional Nanomedicine. , 2016, Bioconjugate chemistry.
[14] Yongjun Wang,et al. Docetaxel prodrug liposomes for tumor therapy: characterization, in vitro and in vivo evaluation , 2016, Drug delivery.
[15] M. Meeus,et al. The effect of docetaxel on developing oedema in patients with breast cancer: a systematic review. , 2016, European journal of cancer care.
[16] W. D. Mcghee,et al. Abstract 4400: Anti-tumor activity of liposomal docetaxel prodrug MNK-010 on PC3 human prostate xenografts in mice , 2015 .
[17] A. Jemal,et al. Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.
[18] P. Calder,et al. Intravenous lipid emulsions , 2014 .
[19] Bingjun Sun,et al. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy. , 2014, Trends in pharmacological sciences.
[20] Yuankai Shi,et al. Development and validation of an ultrafiltration-UPLC-MS/MS method for rapid quantification of unbound docetaxel in human plasma. , 2014, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[21] F. Liu,et al. Disulfide Bond Bridge Insertion Turns Hydrophobic Anticancer Prodrugs into Self-Assembled Nanomedicines , 2014, Nano letters.
[22] R. Murthy,et al. Is an Alternative Drug Delivery System Needed for Docetaxel? The Role of Controlling Epimerization in Formulations and Beyond , 2013, Pharmaceutical Research.
[23] Yuankai Shi,et al. Development and validation of a rapid and sensitive UPLC-MS/MS method for determination of total docetaxel from a lipid microsphere formulation in human plasma. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[24] Shaobin Li,et al. The powerful applications of polyunsaturated fatty acids in improving the therapeutic efficacy of anticancer drugs , 2012, Expert opinion on drug delivery.
[25] Wanyi Tai,et al. Prodrugs for improving tumor targetability and efficiency. , 2011, Advanced drug delivery reviews.
[26] Qiang Zhang,et al. The therapeutic efficacy of conjugated linoleic acid - paclitaxel on glioma in the rat. , 2010, Biomaterials.
[27] C. Bocca. Anti-cancer effect of CLA: A matter of multiple interactions between signalling pathways involving Src, IGF and PPAR-γ pathway? , 2010 .
[28] C. Bocca,et al. CLA reduces breast cancer cell growth and invasion through ERalpha and PI3K/Akt pathways. , 2010, Chemico-biological interactions.
[29] S. Rannard,et al. Nanomedicine: Not a case of “One size fits all” , 2009 .
[30] J. Ajani,et al. Docetaxel-related side effects and their management. , 2009, European journal of oncology nursing : the official journal of European Oncology Nursing Society.
[31] Jin Sun,et al. Preparation and Characterization of a Submicron Lipid Emulsion of Docetaxel: Submicron Lipid Emulsion of Docetaxel , 2008, Drug development and industrial pharmacy.
[32] A. Hutcheon,et al. Potentiation of the anti-tumour effect of docetaxel by conjugated linoleic acids (CLAs) in breast cancer cells in vitro. , 2007, Prostaglandins, leukotrienes, and essential fatty acids.
[33] M. Botta,et al. Paclitaxel And Docetaxel Resistance: Molecular Mechanisms and Development of New Generation Taxanes , 2007, ChemMedChem.
[34] Robert J. Gillies,et al. Docetaxel induces cell death through mitotic catastrophe in human breast cancer cells , 2005, Molecular Cancer Therapeutics.
[35] S. Banni,et al. Incorporation and metabolism of c9,t11 and t10,c12 conjugated linoleic acid (CLA) isomers in rat brain. , 2005, Biochimica et biophysica acta.
[36] M. Nakano. Places of emulsions in drug delivery. , 2000, Advanced drug delivery reviews.
[37] K. Uoto,et al. Synthesis and structure-activity relationships of novel 2',2'-difluoro analogues of docetaxel. , 1997, Chemical & pharmaceutical bulletin.
[38] J. Whelan,et al. Linoleic acid. , 2013, Advances in nutrition.
[39] L. Kastl,et al. miRNA-34a is associated with docetaxel resistance in human breast cancer cells , 2011, Breast Cancer Research and Treatment.
[40] K. Lyseng-Williamson,et al. Docetaxel: a review of its use in metastatic breast cancer. , 2005, Drugs.